Kushima M, Kushima R, Hattori T, Tomoyoshi T
Department of Urology, Shiga University of Medical Science, Japan.
Urol Res. 1995;23(6):381-6. doi: 10.1007/BF00698739.
With special attention to the presence of polyploid cells, we examined heterogeneity and progression of renal cell carcinomas. We separated 116 blocks from 51 tumors into several specimens according to the histologic findings, and analyzed their DNA ploidy patterns. Thirty-one tumors (61%) were aneuploid, 29 of which showed intratumoral DNA ploidy heterogeneity. Diploid cell lines were observed in 47 tumors (92%). Polyploid cells in the diploid component were more frequently found in tumors with mixed diploid and aneuploid patterns than in the purely diploid tumors. Of the diploid cases, higher stage cases tended to have a higher incidence of polyploid cells than the lower stage cases. The incidence of aneuploid cases and DNA heterogeneity became greater as the tumors progressed. Aneuploid cases had a poorer outcome than did the diploid cases. If diploid cases with polyploid cells were classified as aneuploid cases, the difference in the survival rate between the diploid and aneuploid cases became more significant. Diploid renal cell carcinomas with polyploid cells may be an intermediate stage between diploidy and aneuploidy. Analyzing renal cell carcinomas for the presence of polyploid cells is useful for differentiating diploidy, which is actually aneuploid, from pure diploidy.
特别关注多倍体细胞的存在,我们研究了肾细胞癌的异质性和进展情况。我们根据组织学结果将来自51个肿瘤的116个组织块分成几个样本,并分析了它们的DNA倍体模式。31个肿瘤(61%)为非整倍体,其中29个显示肿瘤内DNA倍体异质性。在47个肿瘤(92%)中观察到二倍体细胞系。与纯二倍体肿瘤相比,在具有二倍体和非整倍体混合模式的肿瘤中,二倍体成分中的多倍体细胞更常见。在二倍体病例中,高分期病例的多倍体细胞发生率往往高于低分期病例。随着肿瘤进展,非整倍体病例和DNA异质性的发生率增加。非整倍体病例的预后比二倍体病例差。如果将有多倍体细胞的二倍体病例归类为非整倍体病例,二倍体和非整倍体病例之间的生存率差异会变得更加显著。有多倍体细胞的二倍体肾细胞癌可能是二倍体和非整倍体之间的中间阶段。分析肾细胞癌中多倍体细胞的存在情况有助于区分实际上是非整倍体的二倍体与纯二倍体。